A recent article on psychiatryadvisor.com gives an overview of the role of tDCS in treating depression in pregnant patients—depression being one of the most common psychiatric disorder experienced during pregnancy.
The article addresses the benefits of using tDCS over conventional pharmaceutical interventions in treating the symptoms of depression in pregnant patients. The article gives an example regarding the use of selective serotonin reuptake inhibitors (SSRI), and its propensity toward increasing the risk for neonatal pulmonary hypertension, cardiovascular malformations, and fetal death. Psychotherapy was also mentioned as being another traditional therapy used in pregnant women with mild depression, however the article then goes on to state that the length of time required to achieve symptom improvement tends to be a huge drawback. tDCS on the other hand, was advantageous for being low cost, easy to use, and had minimal side effects.
For more on this article—and on tDCS in treating depression during pregnancy, click the link below:
